Cumberland Pharmaceuticals Inc.
CPIX
$5.72
-$0.14-2.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -133.02% | 27.26% | -162.02% | -158.92% | 166.03% |
| Total Depreciation and Amortization | 17.66% | 0.31% | 0.30% | 0.17% | -26.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.68% | 3,468.57% | -141.18% | -95.68% | 149.36% |
| Change in Net Operating Assets | 6,689.11% | -103.75% | 214.67% | -77.22% | -53.50% |
| Cash from Operations | 12,800.00% | -98.40% | -77.81% | -78.36% | 104.69% |
| Capital Expenditure | -- | 100.00% | 10.19% | 44.33% | -1,969.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.01% | -360.76% | -313.51% | 126.46% | -4,718.78% |
| Cash from Investing | 98.01% | -344.89% | -341.62% | 123.28% | -4,482.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -58.90% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | 100.00% | -44.44% | 97.07% | -149.90% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.02% | -81.11% | -162.12% | 71.90% | -10.01% |
| Cash from Financing | -11.97% | -76.20% | -156.56% | 97.27% | -300.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.34% | -321.35% | -190.97% | 134.28% | -671.85% |